Methodology
| Rationale
| Data Analysis
| Data Interpretation
Methodology
Qualitative and quantitative market research
is integral to Spectra’s publication
strategy to ensure that its study reports
are current, comprehensive, authentic, and
data driven. Core research activities include:
-
Primary data collection
(ie. structured field surveys, direct
communication and interviews, primary
research-based studies, proprietary databases);
-
Secondary data collection
(ie. review data from public sources,
company information, media and trade press);
-
Tertiary data collection
(ie. data derived from peer-reviewed publications
such as journals and books, internet research,
news sources, and data from industry associations
and societies).
Research data are compiled and edited by
leading independent analysts who have the
necessary skills and expertise to interpret
data for objective and predictive analysis.
This ensures our research-based reports
are providing essential time-sensitive commercial
and academic information to key decision-makers
to facilitate strategic management decisions
and assist in corporate development.
Rationale
Spectra Reports are designed to critically
evaluate and investigate core themes in
the global life sciences industry and to
provide in-depth assessments of therapeutics,
innovation and issues affecting the global
marketplace. Spectra’s rationale for
publication involves satisfying the following
key criteria:
-
Comprehensive analyses
of products, technologies, issues and
markets
-
Evaluation of product
positioning for competitive benchmarking
-
Conducting predictive
modelling for product sales and therapeutic
market sectors
-
Presenting trend analysis
of past and present industry activities
-
Providing insightful
discourse to stimulate further research
-
Delivering quality
data for competitive analysis
-
Creating pragmatic
solutions and opportunities for commercial
development
-
Provision of hypothetical
analyses of future events and activities
-
Delivering structured
in-depth extensive data for corporate
and product profiling
-
Origination of new
data, concepts, and foundations for strategic
growth and portfolio management
Data Analysis
Spectra utilises the skills of experienced
analytical experts, research specialists,
and academics to present information that
is highly informative, insightful and comprehensive
that enables rapid knowledge transfer and
acquisition for time-urgent board level
decision-makers. Data is analysed by careful
selection and identification of key events,
activities, forecasts, and pipeline prospects
so that information can be used as the basis
for capital investment, product licensing,
corporate acquisition and mergers, or research
and development efforts.
Data analysis may involve proprietary techniques
and market modelling variables which focus
on:
-
Epidemiological and
demographic data;
-
Prescribing trends;
-
Regulatory reforms;
-
Drug dossier and regulatory
filing data;
-
Historical product
performance factors;
-
Market leaders;
-
Key opinion leaders;
-
Clinical practitioners;
-
Intellectual property
assets;
-
Growth rates;
-
Market assumption validation;
-
Company profiles.
Data validation is supported where appropriate
by comparative analysis with industry organisations,
company product revenues, and growth predictions
from key industry sources.
Data Interpretation
Spectra Intelligence collates primary,
secondary, and tertiary biomedical and commercial
data to comprehensively analyse markets,
products, therapeutic sectors, and current
commercial issues. Collective data is used
to objectively interpret information for
clients in the life sciences arena. Spectra
research analysts extrapolate salient features
during the data analysis process to highlight
new opportunities, potential threats, high-growth
prospects, management strategies, and niche
areas for product exploitation and development.
We aim to offer highly regarded objective
interpretations of developments within the
pharmaceutical, biotechnology, and medical
devices fields, which are intended to help
clients benchmark their corporate goals
and strategies against major competitors
so that they may optimise their position
in the industry and maintain innovation,
growth, and prosperity.
We do not simply redistribute or repackage
previous published information but work
from the ground up to deliver new generation
bespoke information products that are well
researched, highly informative, and which
present new insights to facilitate business
development for a highly innovative and
advancing industry.
|
